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Abstract 
Intracellular calcium (Ca2+) signals are key regulators of multiple cellular functions: both 
healthy and physiopathological. It is therefore unsurprising that several cancers present a 
strong Ca2+ homeostasis deregulation. Among the various hallmarks of cancer disease, a 
particular role is played by metastasis, which has a critical impact on cancer patients’ 
outcome. Importantly, Ca2+ signalling has been reported to control multiple aspects of the 
adaptive metastatic cancer cell behavior, including epithelial-mesenchymal transition, cell 
migration, local invasion and induction of angiogenesis (Fig. 1). In this context Ca2+ 
signalling is considered to be a substantial intracellular tool that regulates the dynamicity and 
complexity of the metastatic cascade. In the present study we review the spatial and temporal 
organization of Ca2+ fluxes, as well as the molecular mechanisms involved in metastasis, 
analyzing the key steps, which regulate initial tumor spread. 
Abbreviations 
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endoplasmic reticulum, ER; epidermal growth factor, EGF; epithelial-mesenchymal 
transition, EMT; extracellular matrix, ECM; hydrogen peroxide, H2O2; sulfhydric acid, H2S; 
human umbilical vein endothelial cell, HUVEC; Ca2+ activated potassium channels, KCa; 
matrix metalloproteinase, MMP; membrane type 1 matrix metalloproteinase, MT1-MMP ; 
Ca2+-dependent myosin light chain kinase, MLCK; myosin II, myo II; sodium, Na+; Na+-Ca2+ 
exchanger, NCX; nuclear factor of activated T-cells, NFAT; nitric oxyde, NO; Ca2+ release-
activated Ca2+ channel protein, ORAI; ligand gated Ca2+ channels, P2X; purinergic G 
protein-coupled receptors, P2Y; phospholipase C, PLC; plasma membrane ATPase, PMCA; 
proline-rich tyrosine kinase 2, Pyk2; reactive oxygen species, ROS; sarco/endoplasmic 
reticulum Ca2+-ATPase, SERCA; store-operated Ca2+ entry, SOCE; stromal interaction 
molecule, STIM; tumor-derived endothelial cells, TECs; transforming growth factor β1, 
TGF-β1; two-pore channel, TPC; transient receptor potential channel, TRP channel; transient 
receptor potential ankyrin channel, TRPA; transient receptor potential canonical channel, 
TRPC; transient receptor potential melastatin channel, TRPM; transient receptor potential 
vanilloid channel, TRPV; vascular endothelial growth factor, VEGF; voltage-gated Ca2+ 
channels, VGCCs. 
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Introduction 
Calcium (Ca2+) is an ubiquitous second messenger which is involved in the tuning of multiple 
fundamental cellular functions (Berridge MJ, Lipp P, 2000). Due to its multifaceted roles, it 
is not therefore surprising that deregulated Ca2+ homeostasis has been observed in various 
disorders, including tumorigenesis (Monteith GR, McAndrew D, Faddy HM, 2007; 
Prevarskaya et al., 2011). Among the various manifestations of cancer, a particular role is 
played by metastasis, which has a critical impact on cancer patients’ outcome (Hanahan & 
Weinberg, 2011). Tumor spread is a highly regulated process that usually starts with the loss 
of cell-cell contact and the epithelial-mesenchymal transition (EMT) (Kalluri & Weinberg, 
2009). During metastasis, cancer cells also acquire enhanced directional movement and 
activate molecular pathways that enable the proteolysis of an extracellular matrix (ECM) as 
well as local angiogenesis. As a result, cancer cells enter the body circulation systems and 
disseminate to distinct sites around the organism. Importantly, Ca2+ signalling has been 
reported to control multiple aspects of the adaptive metastatic cancer cell behaviors, 
including EMT, migration, local angiogenesis induction and intravasation (Chen et al., 2013). 
In this context, it is considered to be a substantial intracellular tool that regulates the 
dynamicity and complexity of the metastatic cascade. Intracellular free Ca2+ concentration is 
highly controlled by the fine regulation of “ON and OFF” mechanisms that ultimately 
generate Ca2+ signals with various amplitudes and frequencies. As regarding the “ON” 
mechanisms, cytosolic Ca2+ can either be delivered from extracellular space due to the 
activity of Ca2+-permeable channels and transporters in plasma membrane, or occur as a 
result of a release from Ca2+ -containing organelles (e.g. endoplasmic reticulum) (Berridge 
MJ, Lipp P, 2000). In order to maintain low resting Ca2+ concentration, cells remove Ca2+ 
using an energy-dependent mechanism, such as plasma membrane ATPases (PMCA), or Na+-
Ca2+ exchanger (NCX). Moreover Ca2+ is sequestered intracellularly into Ca2+ -containing 
organelles, primarily endoplasmic reticulum (ER), by means of mechanisms which require 
either ATP hydrolysis (e.g. a SERCA pump), or a favorable electrochemical gradient. In this 
review we will overview the spatial and temporal organization of Ca2+ fluxes as well as those 
molecular mechanisms involved in metastasis, analyzing the key steps which regulate tumor 
spread. 
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Epithelial-mesenchymal transition and loss of cell-cell contact 
EMT is a cellular process during which epithelial cells acquire a fibroblast-like morphology. 
This process involves changes in cellular shape, a loss of epithelial polarized organization 
and cell-cell contacts like tight and adherens junctions. Accordingly, one of the most 
recognized features of cells undergoing EMT, is a suppression of multiple epithelial markers 
(e.g. E-cadherin, claudins, occludins) and an overexpression of mesenchymal markers (e.g. 
N-cadherin, vimentin, integrins) (Fig.2). 
Of note, EMT and the disruption of cell-cell contact is one of the key events in tumor 
progression. This can be induced by various effectors like growth factors, hypoxia, and 
inflammation (Diepenbruck & Christofori, 2016). Interestingly, the remodeling of Ca2+ 
signals during EMT processes has been reported for a variety of cancer cells. For example, in 
breast cancer cells, the potency of ATP-mediated cytosolic Ca2+ transients exhibits significant 
changes after epidermal growth factor (EGF) and hypoxia-induced EMT (Davis et al., 2011; 
Azimi et al., 2016). Specifically, an attenuation of the cytosolic Ca2+ peak and a sustained 
phase of Ca2+ influx in the response to ATP, have been attributed to the activity of G-protein-
coupled purinergic receptors (P2Y family) and ligand-gated Ca2+ channels (P2X family) 
(Davis et al., 2011; Azimi et al., 2016). Another study reveals that an inhibition of P2X5 
reduces the expression of the EMT marker vimentin, whereas its increased expression 
correlates with breast cancer cells that are associated with a more mesenchymal phenotype 
(Davis et al., 2011). Moreover, the chelation of free cytosolic Ca2+ suppresses the production 
of mesenchymal markers like vimentin, N-Cadherin and CD44, after the exposure of breast 
cancer cells to EGF and hypoxia (Davis et al., 2013; Stewart et al., 2015). Similar findings 
have been reported for hepatic cancer cells, where chelation of intracellular Ca2+ reversed 
doxorubicin-induced EMT (Wen et al., 2016). Furthermore, the EMT of colon cancer cells 
may be regulated by the small conductance calcium-activated channel, subfamily N, such as 
KCNN4 through Ca2+-dependent mechanisms (Lai et al., 2013). Regarding the store-operated 
Ca2+ entry (SOCE), the data is ambiguous. On one hand, SOCE and basal Ca2+ influx are 
reduced after the EGF-induction of EMT in the MDA-MD-468 breast cancer cell line (Davis 
et al., 2012). On the other hand, the transforming growth factor β1 (TGF-β1)-induced EMT is 
associated with enhanced SOCE in the MCF-7 breast cancer cell line (Hu et al., 2011).  
 It is now clear that the remodelling of Ca2+ signalling is a prominent feature of EMT 
in various cancer types. Therefore, a deregulation of Ca2+-permeable channels could subserve 
as an important EMT regulator during carcinogenesis. Indeed, silencing and pharmacological 
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inhibition of transient receptor potential melastatin channels (TRPM) such as TRPM7 and 
TRPM8 reduce the expression of a variety of mesenchymal markers in breast cancer cells 
(Davis et al., 2013; Liu et al., 2014). In the MCF-7 breast cancer cell line that exhibits a more 
epithelial-like phenotype, the overexpression of TRPM8 leads to EMT induction as indicated 
by the profile of markers expressed (Liu et al., 2014). Consistent with this data, TRPM8 has 
been found to be upregulated in breast cancer tumor tissues, when compared to adjacent 
nontumor tissues, thereby suggesting the role of TRPM8 as a determinant of EMT transition 
(Liu et al., 2014). Moreover, in breast cancer cells, EGF-induced EMT significantly increases 
the mRNA level of Ca2+ release-activated Ca2+ channel protein 1 (ORAI1) and leads to 
altered Ca2+ signalling, possibly due to the involvement of transient receptor potential 
canonical channel type 1 (TRPC1) (Davis et al., 2012). In hepatic cancer cells, another 
member of the transient receptor potential canonical channel family,  TRPC6 has been shown 
to affect the expression of EMT markers after doxorubicin induction (Wen et al., 2016).  
 Overall, the studies of Ca2+ signalling and Ca2+-permeable channels using various 
cancer models and EMT effectors have defined a critical role for the Ca2+ signal in the EMT 
process during tumorigenesis. 
Cell migration 
The principal component of cancer cell motility is directional migration, which is due to  
front-rear end polarity (Mayor & Etienne-Manneville, 2016). Typically, the leading edge is 
represented by flat cell membrane extensions with directed actin polymerization and nascent 
attachment sites, whereas at the rear of the cell, adhesions are disassembled and the trailing 
edge is contracted (Mayor & Etienne-Manneville, 2016). Interestingly, global cytosolic Ca2+ 
is generally higher at the rear end, whereas Ca2+ flickers are enriched near the front edge 
(Evans et al., 2007; Wei et al., 2009; Tsai & Meyer, 2012). It is suggested that such Ca2+ 
distribution is involved in controlling the directed cellular locomotion (Brundage RA, 
Fogarty KE, Tuft RA, 1991).  
Of note, migration is a complex and multistep process that involves coordination 
between cytoskeleton remodeling, cell-substrate adhesion/detachment and cellular 
protrusion/contraction (Gardel et al., 2010; Thomas Parsons et al., 2010). Importantly, 
several key molecular components and signalling events of the cellular migration machinery 
are Ca2+-sensitive (Fig. 3). For example, the myosin II-based (myo II) actomyosin contraction 
is mainly mediated through the activity of Ca2+-dependent myosin light chain kinase (MLCK) 
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(Clark et al., 2007). The focal adhesion turnover is also highly dependent on Ca2+ signalling. 
On the one hand, the disassembly of cell adhesions is achieved due to the cleavage of focal 
adhesion proteins, such as integrins, talin, vinculin and focal adhesion kinases, by the Ca2+-
sensitive protease, calpain (Franco SJ, 2005). On the other hand, Ca2+ is important for the 
modulation of nascent focal adhesion sites by activating proline-rich tyrosine kinase 2 
(Pyk2), and small GTPases like Ras and Rac (Lysechko et al., 2010; Selitrennik & Lev, 
2015). S100 proteins, a subgroup of the EF-hand Ca2+-binding protein family, regulate a 
variety of cellular processes via an interaction with different target proteins (Bresnick et al., 
2015). In particular, their influence on F-actin polymerization and myo II-actin assembly has 
been suggested as governing cell migration due to the cytoskeletal structural remodeling 
(Gross et al., 2014) (Fig.3 ). Overall, it is now clear that cell migration can be considered as a 
Ca2+-dependent process. Importantly, Ca2+-permeable channels are responsible for the 
cytosolic Ca2+ delivery from external and internal cellular stores. Therefore, their activity 
would define the occurrence of those sustained and transient Ca2+ changes which are 
important for the orchestration of cellular migration. 
Interestingly, in migrating erythrocytes and human umbilical vein endothelial cells, 
the low basal Ca2+ levels at the leading edge are maintained due to the activity of PMCA and 
the inhibition of PMCA leads to an abrogated front-to-rear Ca2+ gradient and decreased 
migration (Pérez-Gordones et al., 2009; Tsai et al., 2014). Similar mechanisms could be 
utilized by the metastatic cells, since the expression of PMCA has been found to directly 
correlate with the tumorigenicity of breast cancer cells (Lee et al., 2005) (Fig. 3). At the same 
time, in the front end of ER, low local Ca2+ concentration provokes high sensitivity to SOCE 
(Tsai et al., 2014). Indeed, the ER residual Ca2+ sensor of SOCE, stromal interaction 
molecule (STIM), has been found to be  distributed along the polar axis in the leading edge of 
the migrating cell (Tsai et al., 2014). The STIM molecule responds to the Ca2+ ER depletion 
and provokes ion influx through the plasma membrane ORAI channel (Liou et al., 2005; 
Roos et al., 2005). Of note, STIM-ORAI proteins have been found to be significantly 
upregulated in various cancer types and SOCE-activated Ca2+ signalling is implemented in 
the mediation of actomyosin assembly and the focal adhesions required for efficient 
migration (Chen et al., 2011; Fiorio Pla et al., 2016; Jardin I, 2016) (Fig. 3). 
Plasma membrane extensions and protrusions play the role of a mechanical stress and 
thus provide Ca2+ influx through stretch-activated channels at the front end of a migrating 
cell. Indeed, TRPM7 can be activated intracellularly through phospholipase C (PLC), or by a 
membrane stretch (Su et al., 2006; Wei et al., 2009; Gao et al., 2011; Middelbeek et al., 
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2012). Interestingly, TRPM7 is located in close proximity to calpain and myo II (Clark et al., 
2007). Therefore, Ca2+ entry provided through TRPM7 modulates actomyosin cytoskeleton 
contraction, as well as the dynamics of the focal adhesion turnover required for directional 
cell migration (Clark et al., 2007). Indeed, the pro-migratory role of TRPM7 has been 
demonstrated for breast, lung, pancreatic and nasopharyngeal cancers (Visser et al., 2014). 
Moreover recently, the mechano-sensitive TRPC1 activation, located at the rear of the cells, 
has been shown to play a role in the formation of cell polarity of U2OS bone osteosarcoma 
cells and their directional migration (Huang et al., 2015). Similarly, several members of TRP 
channel family have been implicated in cell migration in various cancer types (Fiorio Pla & 
Gkika, 2013). In particular most TRP channels have been associated with an increase in 
migration potential. This is the case for TRPC members such as TRPC1, TRPC6 in glioma 
cells (Chigurupati et al., 2010; Bomben et al., 2011). In addition, the vanilloid subfamily 
TRPV2, has also been associated with increased cellular migration in prostate, bladder and 
breast cancer (Oulidi et al., 2013; Gambade et al., 2016). In contrast, full length TRPM8, has 
been reported to inhibit cell migration, thus suggesting a protective role for TRPM8 in 
prostate metastatic cancer progression (Gkika et al., 2010, 2015), whereas the short TRPM8 
isoform could have a pro-metastatic potential (Peng et al., 2015; Bidaux et al., 2016).  
Voltage-gated Ca2+ channels (VGCCs) present another pathway for Ca2+ influx that 
activates a downstream MAPK/ERK signalling pathway and increases migration (Mertens-
Walker et al., 2010). In particular, Cav1.3 has been found to be overexpressed in endometrial 
carcinoma and its knockdown has been shown to reduce migration (Hao et al., 2015). Indeed, 
at filopodia tips increased Ca2+ concentration provided through L-type VGCCs directs cancer 
cell migration due to calpain activation (Jacquemet et al., 2016).  
Intracellular Ca2+ is an important regulator of Ca2+ activated potassium channels 
(KCa). Furthermore, ORAI and TRPC1 channels may form complexes with small 
conductance KCa channel SK3 (Chantome et al., 2013; Guéguinou et al., 2016). Such a SK3-
ORAI complex is crucial for the migratory function of breast and prostate cancer cells and 
has been found in bone metastasis (Chantome et al., 2013). Similarly, colon cancer cell 
migration is dependent on SOCE through the SK3/TRPC1/Orai1 channel complex 
(Guéguinou et al., 2016). 
 
Invasiveness and invadopodia formation 
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The invasiveness of cancer cells is due to their ability to degrade ECM and migrate into 
neighboring connective tissues as well as the lymph- and bloodstreams. There, cancer cells 
spread throughout the organism and give rise to secondary tumor outbursts, metastases. 
Consequently, the understanding and hence prevention of the process of cancer cell invasion 
would remarkably improve the survival rate of cancer patients. Cancer cell invasion is 
achieved due to special structures – invadopodia, which are dynamic actin-enriched cell 
protrusions with proteolytic activity. Typically, the invadopodia formation process can be 
differentiated into the following steps: initiation, assembly and maturation (Fig.4) (Jacob et 
al., 2015). The assembly of invadopodia is initiated in response to the focal generation of 
phosphatidylinositol-3,4-biphosphate and the activation of the nonreceptor tyrosine kinase 
Src (Mader et al., 2011; Pan et al., 2011; Yamaguchi H & Sakai R, 2011). The matured 
invadopodia recruit proteolytic enzymes, such as membrane type 1 (MT1)–matrix 
metalloproteinase (MMP), MMP2, and MMP9, to facilitate the focal degradation of the 
extracellular matrix and allow cell invasion (Beaty et al., 2013). 
 Intruigingly, a particular pattern of Ca2+ signalling, Ca2+ oscillations, has been 
revealed as predisposing factor for invadopodia formation and activity (Fig. 4) (Sun et al., 
2014). For example, Ca2+ oscillations mediated through STIM1 and ORAI1 channels have 
been reported to activate Src kinase and hence facilitate the assembly of invadopodial 
precursors in melanoma cells (Sun et al., 2014). The proteolytic activity of invadopodia is 
predetermined by the incorporation of MMP-containing endocytic vesicles into the plasma 
membrane at the ECM degradation sites and can also be linked to Ca2+ signalling machinery 
(Bravo-Cordero JJ et al., 2007). Indeed, the inhibition of SOCE-abrogated fusion of MMP-
containing vesicles with the plasma membrane result in a constrained ECM degradation (Sun 
et al., 2014). Moreover, constitutively active TRPV2 engenders an intracellular Ca2+ increase 
and has been associated with an upregulation of MMP9 and the invasive potential of prostate 
cancer cells (Monet et al., 2010). In oral squamous carcinoma, TRPM8 activity directly 
correlates with MMP9 activity and the metastatic potential of cells (Okamoto et al., 2012). 
The downregulation of MMP9 might also be achieved after the inhibition of VGCCs (Kato et 
al., 2007). Furthermore, in the highly metastatic MDA-MB-435 human breast cancer cell 
line, the activity of the ATP-gated Ca2+-permeable P2X7 receptor increases invasion by the 
release of gelatinolytic cysteine cathepsins (Jelassi et al., 2011). Therefore, in invadopodia, 
Ca2+ influx is required for the focal degradation of ECM, in particular through the 
upregulation of proteolytic enzymes like MMPs and cathepsins, whereas Ca2+ oscillations are 
required for the initiation of the invadopodia formation process (Fig. 4). 
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Induction of local angiogenesis 
The first mechanical and functional interface between blood and tissues is blood vessels. 
Thus, in order to sustain metastatic dissemination, as well as providing sufficient metabolic 
support, tumor neovascularization is required. Indeed, tumor cells enable the ‘activation’ of 
the nearby endothelial cells (ECs) due to the secretion of specific molecules, such as vascular 
endothelial growth factor (VEGF). Hence, the complex and multistep process of angiogenesis 
is achieved due to the proliferation, migration, differentiation and stabilization of such tumor-
derived ECs (TECs) in a new circulatory network (Carmeliet, 2005; Folkman J, 2006).  
 It should be noted that in tumors of various origins, Ca2+ signalling has been shown to 
regulate the release of VEGF and hence modulate angiogenesis (Fig. 5). For example, plasma 
membrane Cav3.2 and ER-residing STIM1 proteins have been shown to promote 
angiogenesis in vivo due to the stimulation of VEGF secretion in both prostate and cervical 
cancers (Chen et al., 2011; Warnier et al., 2015). Moreover, the importance of TRPC6 as a 
modulator of angiogenic potential has been revealed in glioma cells (Chigurupati et al., 
2010). According to this study, the number of EC branch points decreases after growing in a 
conditioned medium harvested from glioma cells, where hypoxia-induced TRPC6 
overexpression and NFAT activation are inhibited (Chigurupati et al., 2010). Of note, methyl 
syringate, which is suggested to be a highly specific and selective agonist of transient 
receptor potential ankyrin channel 1 (TRPA1) suppresses the hypoxia-induced migration, 
invasion and secretion of VEGF in human lung epithelial cells (Park et al., 2016).  
Importantly, during tumor neovascularization, the remodeling of Ca2+ machinery has 
been associated not only with the angiogenic potential of cancer cells, but also with the 
distinct functions of the ‘activated’ endothelium cells (Fig. 5). Indeed, proangiogenic Ca2+ 
signals and their related pathways are significantly altered in TEC, compared with normal EC 
(Fiorio Pla & Munaron, 2014). As an example, Ca2+ signals mediated by specific factors like 
VEGF and ATP and intracellular messengers such as arachidonic acid (AA), nitric oxyde 
(NO), or sulfhydric acid (H2S) and cyclic AMP (cAMP) are involved in pro-migratory effects 
in TEC, but not in normal EC (Fiorio Pla et al., 2008, 2010, 2012b; Pupo et al., 2011; 
Avanzato et al., 2016).  
Moreover, the role of intracellular Ca2+ increase has been investigated at length in 
endothelium (Fiorio Pla & Munaron, 2014). Both pro- and antiangiogenic molecules can 
induce an intracellular Ca2+ increase, often leading to different biological effects. For 
instance, Ca2+ entry triggered by VEGF, as well as by other proangiogenic factors, is often 
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associated with an increase in vessel permeability, EC survival/proliferation, migration and in 
vitro tubulogenesis (Dragoni et al., 2011, 2015; Li et al., 2011). These outcomes can be 
achieved by the activation of a distinct intracellular mechanism, such as SOCE via ORAI and 
TRPC1 channels (Mehta et al., 2003; Paria et al., 2004; Jho et al., 2005; Abdullaev et al., 
2008; Dragoni et al., 2011; Li et al., 2011; Fiorio Pla & Munaron, 2014), non-SOCE 
mechanisms via TRPC6 channels (Cheng et al., 2006; Hamdollah Zadeh et al., 2008), the 
specific engagement of the two-pore channel TPC2 subtype on acidic intracellular Ca2+ 
stores, resulting in Ca2+ release and angiogenic responses (Favia et al., 2014), or by reverse 
mode activation of NCX (Fig. 5) (Andrikopoulos et al., 2011). Of note, in a recent study 
VEGF-mediated Ca2+ signalling in individual endothelial cells has been investigated and 
shown to correlate both stochastic and deterministic response characteristics to the selection 
of phenotype-associated angiogenesis. In particular, altering the amount of VEGF signalling 
in endothelial cells by stimulating them with different VEGF concentrations, triggered 
distinct and mutually exclusive dynamic Ca2+ signalling responses, that correlated with 
different cellular behaviors such as cell proliferation, (monitored by NFAT nuclear 
translocation) or cell migration (involving MLCK) (Noren et al., 2016). The in vivo role of 
Ca2+ signals has been recently studied in zebrafish, during angiogenic input by means of 
high-speed, three-dimensional time-lapse imaging to describe intracellular Ca2+ dynamics in 
ECs at single-cell resolution (Yokota et al., 2015; Noren et al., 2016). It may be noted that 
TRP Ca2+-permeable channels have profound effects on the control of different steps of 
tumor angiogenesis. Besides their role in the VEGF-mediated Ca2+-signals previously 
described, several data clearly show their involvement Ca2+ mediated signal transduction with 
prominent roles in tumor angiogenesis. In this context, TRPV4 is an emerging player in 
angiogenesis, as on EC it acts as a mechano-sensor during changes in cell morphology, cell 
swelling and shear stress. TRPV4 plays a significant role in endothelial migration, (Fiorio Pla 
et al., 2012b) displaying a marked increase in EC derived from human breast carcinomas, as 
compared with ‘normal’ EC, leading to a greater Ca2+ entry that in turn activates migration in 
TEC (Fig. 5) (Fiorio Pla et al., 2012b). Moreover, TRPV4 has recently been described as an 
important player in tumor vasculature normalization, therefore potentially improving cancer 
therapies (Adapala et al., 2015; Thoppil et al., 2015, 2016). In addition, TRPM2 has been 
recently identified as mediating an H2O2-dependent increase in macro-vascular pulmonary 
EC permeability (Fig. 5) (Hecquet et al., 2008; Mittal et al., 2015). TRPM7 inhibits HUVEC 
proliferation and migration, whereas its functions in human mammary epithelial cells seem to 
be opposite (Fig. 5) (Inoue & Xiong, 2009; Baldoli & Maier, 2012; Baldoli et al., 2013; Zeng 
11 
 
et al., 2015). Recently, TRPA1 has been found to have a role in the vasodilatation of cerebral 
arteries, via an increase in Ca2+ influx generated by the detection of ROS, a process that 
requires the peroxidation of membrane lipids (Sullivan et al., 2015). Similarly, TRPV2 has 
been shown to be expressed in aorta endothelium, but no clear functional data have been 
reported (Earley, 2011). 
Finally, the emerging family of mechanosensitive Piezo channels has recently been 
described in vascular endothelial cells: Piezo2 knockdown is involved in glioma 
angiogenesis, both in vitro as well as in vivo by promoting abnormal intracellular Ca2+, 
Wnt11/β-catenin signalling reduction, leading to altered angiogenic activity of endothelial 
cells (Fig. 5) (Yang et al., 2016).  
In conclusion, due to its multifaceted role in the control of endothelium homeostasis, 
Ca2+ machinery is a potential molecular target for strategies against tumor neovascularization. 
Conclusions 
A remodeling of Ca2+ signalling plays an important role during tumorigenesis. Interestingly, 
there are some specific channel patterns through which such Ca2+ signals occur, at the 
different stages of cancer progression. This could be partially explained by the specificity of 
Ca2+ flux, its compartment localization and the proximity of downstream Ca2+-dependent 
targets. Furthermore, some ion channels represent multimodal activity and are characterized 
as not only Ca2+-permeable pore proteins, but also possess other functional domains. For 
example, the C-terminal end of TRPM7 is constituted by a serine/threonine protein kinase 
domain and hence, due to the phosphorylation of cytoskeletal components, regulates cellular 
migration (Clark et al., 2008).  
Importantly, plasma membrane Ca2+ channels are easily and directly accessible via 
the bloodstream. Therefore, they are potential targets for a variety of therapeutic strategies, 
such as their regulation on a transcriptional and translational level, their trafficking to the 
plasma membrane or their stabilization at the plasma membrane (Gkika & Prevarskaya, 2009; 
Fiorio Pla et al., 2012a; Bernardini et al., 2015; Earley & Brayden, 2015). 
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Figure legends 
Fig. 1. Abstract figure. Model of the specific patterns of Ca2+ signals that are associated with 
different steps of cancer progression. It is important to note that most of the findings on Ca2+ 
signalling have been generated in vitro. Therefore, it is possible that in tissues, Ca2+ signals 
do not simply follow the same patterns. 
Fig. 2. Epithelial-to-mesenchymal transition (EMT) and a loss of cell-cell contacts and 
downregulation of proteins such as E-cadherin, Claudin or Occludin. EMT transition is 
accompanied by the changes in Ca2+ signals due to several factors such as growth factors, 
cytokines or hypoxia. The most studied Ca2+-permeable channels, which are associated with 
EMT, are indicated. 
Fig. 3. Global cytosolic Ca2+ is generally higher at the rear (marked in red), whereas Ca2+ 
flickers are enriched near the front edge of migrating cell. The key molecular components 
and signalling events of the cellular migration machinery are Ca2+-dependent. The most 
studied Ca2+-permeable channels, which are associated with directional migration, are 
indicated. 
13 
 
Fig. 4. Ca2+ oscillations are required for the initiation of the invadopodia formation process, 
whereas Ca2+ influx activates the focal degradation of the extracellular matrix (ECM), in 
particular through the upregulation of the proteolytic enzymes like matrix metallo-proteinases 
(MMPs) and cathepsins. The most studied Ca2+-permeable channels, which are associated 
with invasiveness, are indicated. 
Fig. 5. Induction of local angiogenesis by Ca2+ signalling remodeling. In tumor cells Ca2+ 
signals regulate the secretion of proangiogenic stimuli, like vascular endothelial growth factor 
(VEGF). A newly formed vessel can be differentiated into following structures: tip – 
represented by the migrating edge of the vessel; stalk – mostly proliferating part of the vessel; 
phalanx – tightly apposed, regularly ordered ECs that provide perfusion and oxygenation; 
mural – functional preformed ECs. Interestingly, VEGF and ATP-mediated Ca2+ signals 
provide proangiogenic effects specifically on tumor derived tissue and not on healthy ECs. 
The most studied Ca2+-permeable channels, which are associated with local angiogenesis, are 
indicated. 
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